Meeting of the Presidential Advisory Council on HIV/AIDS, 4268-4269 [2015-01428]
Download as PDF
asabaliauskas on DSK5VPTVN1PROD with NOTICES
4268
Federal Register / Vol. 80, No. 17 / Tuesday, January 27, 2015 / Notices
numbers above each band
representing the fold change human
prostate cancer cell lines; the numbers
above each band representing the fold
change in expression relative to the
DMSO control also were falsified for
p-ACLY (LNCaP cell line) and p-Akt
(PC3 and LNCaP cell lines) compared
to the values provided to the
Respondent
• falsified Figure 4D by substituting
bands for p-ACLY for those provided
to him to allow Respondent to claim
that Z-Gug significantly inhibited
phosphorylation of ACLY in lysates of
prostate tumors obtained from mice,
when the original data showed no
effect
• falsified Figures 5C and 5D to show
that treatment of PC3 and LNCaP cells
with Z-Gug alone and with Z-Gug
plus si-RNA targets to ACLY
stimulated Caspase 3/7 activity, when
the original data provided to him
showed no significant effect of either
treatment in PC3 cells and no effect of
Z-Gug alone in LNCaP cells
• falsified Figures 6G and 6H; these
figures purported to show that Nacetyl-L-cysteine (NAC), an inhibitor
of reactive oxygen species (ROS),
reversed the inhibition of Akt
phosphorylation caused by Z-Gug in
PC3 cells (Figure 6G) and LNCaP cells
(Figure 6G) when no Akt data for this
protocol was available to the
Respondent; Respondent admitted to
falsifying Figure 6G
• falsified Figures S2B and S3B by
altering data provided to him; these
experiments are complementary to
those shown in Figures 5C and 5D,
except that the effect of Z-Gug and Zgug plus si-RNA on Caspase 3/7
activity utilized on si-RNA was
directed to Akt activity. The original
data showed no significant effect of
either treatment in PC3 cells and no
effect of Z-Gug on LNCaP cells, while
both treatments were claimed to be
significant inducers of caspase
activity in both cell lines in the
published figures.
Dr. Xiao has entered into a Voluntary
Settlement Agreement (Agreement) and
has voluntarily agreed for a period of
three (3) years, beginning on December
23, 2014:
(1) To have his research supervised;
Respondent agreed to ensure that prior
to the submission of an application for
U.S. Public Health Service (PHS)
support for a research project on which
the Respondent’s participation is
proposed and prior to Respondent’s
participation in any capacity on PHSsupported research, the institution
employing him must submit a plan for
VerDate Sep<11>2014
18:01 Jan 26, 2015
Jkt 235001
supervision of his duties to ORI for
approval; the plan for supervision must
be designed to ensure the scientific
integrity of Respondent’s research
contribution; Respondent agreed that he
will not participate in any PHSsupported research until such a
supervision plan is submitted to and
approved by ORI; Respondent agreed to
maintain responsibility for compliance
with the agreed upon plan for
supervision;
(2) that any institution employing him
must submit, in conjunction with each
application for PHS funds, or report,
manuscript, or abstract involving PHSsupported research in which
Respondent is involved, a certification
to ORI that the data provided by
Respondent are based on actual
experiments or are otherwise
legitimately derived and that the data,
procedures, and methodology are
accurately reported in the application,
report, manuscript, or abstract; and
(3) to exclude himself voluntarily
from serving in any advisory capacity to
PHS including, but not limited to,
service on any PHS advisory committee,
board, and/or peer review committee, or
as a consultant.
FOR FURTHER INFORMATION CONTACT:
Acting Director, Office of Research
Integrity, 1101 Wootton Parkway, Suite
750, Rockville, MD 20852, (240) 453–
8200.
Donald Wright,
Acting Director, Office of Research Integrity.
[FR Doc. 2015–01427 Filed 1–26–15; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Notice of Interest Rate on Overdue
Debts
Section 30.18 of the Department of
Health and Human Services’ claims
collection regulations (45 CFR part 30)
provides that the Secretary shall charge
an annual rate of interest, which is
determined and fixed by the Secretary
of the Treasury after considering private
consumer rates of interest on the date
that the Department of Health and
Human Services becomes entitled to
recovery. The rate cannot be lower than
the Department of Treasury’s current
value of funds rate or the applicable rate
determined from the ‘‘Schedule of
Certified Interest Rates with Range of
Maturities’’ unless the Secretary waives
interest in whole or part, or a different
rate is prescribed by statute, contract, or
repayment agreement. The Secretary of
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
the Treasury may revise this rate
quarterly. The Department of Health and
Human Services publishes this rate in
the Federal Register.
The current rate of 101⁄2%, as fixed by
the Secretary of the Treasury, is certified
for the quarter ended December 31,
2014. This rate is based on the Interest
Rates for Specific Legislation, ‘‘National
Health Services Corps Scholarship
Program (42 U.S.C. 250(B)(1)(A))’’ and
‘‘National Research Service Award
Program (42 U.S.C. 288(c)(4)(B)).’’ This
interest rate will be applied to overdue
debt until the Department of Health and
Human Services publishes a revision.
Dated: January 15, 2015.
David C. Horn,
Director, Office of Financial Policy and
Reporting.
[FR Doc. 2015–01429 Filed 1–26–15; 8:45 am]
BILLING CODE 4150–04–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on HIV/AIDS
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Service (DHHS) is hereby giving notice
that the Presidential Advisory Council
on HIV/AIDS (PACHA) will hold a
meeting to discuss essential health
benefits and provider networks, the
integration of the Affordable Care Act
(ACA) qualified health plan and the
Ryan White Program; an update on the
National HIV/AIDS Strategy; and a
discussion on surveillance data. The
meeting will be open to the public.
DATES: The meeting will be held on
February 12, 2015, from 9 a.m. to
approximately 5 p.m. (ET) and February
13, 2015, from 9:30 a.m. to
approximately 12:30 p.m. (ET).
ADDRESSES: Renaissance Washington
DC, Downtown Hotel, 999 Ninth Street
NW., Washington, DC 20001.
FOR FURTHER INFORMATION CONTACT: Ms.
Caroline Talev, Public Health Analyst,
Presidential Advisory Council on HIV/
AIDS, U.S. Department of Health and
Human Services, 200 Independence
Avenue SW., Room 443H, Washington,
DC 20201; (202) 205–1178. More
detailed information about PACHA can
be obtained by accessing the PACHA
Web page on the AIDS.Gov Web site at
www.aids.gov/pacha.
SUMMARY:
E:\FR\FM\27JAN1.SGM
27JAN1
Federal Register / Vol. 80, No. 17 / Tuesday, January 27, 2015 / Notices
PACHA
was established by Executive Order
12963, dated June 14, 1995, as amended
by Executive Order 13009, dated June
14, 1996. The Council was established
to provide advice, information, and
recommendations to the Secretary
regarding programs and policies
intended to promote effective
prevention of HIV disease and AIDS.
The functions of the Council are solely
advisory in nature.
The Council consists of not more than
25 members. Council members are
selected from prominent community
leaders with particular expertise in, or
knowledge of, matters concerning HIV
and AIDS, public health, global health,
philanthropy, marketing or business, as
well as other national leaders held in
high esteem from other sectors of
society. Council members are appointed
by the Secretary or designee, in
consultation with the White House
Office on National AIDS Policy. The
agenda for the upcoming meeting will
be posted on the Council’s Web site at
www.aids.gov/pacha.
Public attendance at the meeting is
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
designated contact person. Due to space
constraints, pre-registration for public
attendance is advisable and can be
accomplished by contacting Caroline
Talev at caroline.talev@hhs.gov by close
of business February 6, 2015. Members
of the public will have the opportunity
to provide comments at the meeting.
Any individual who wishes to
participate in the public comment
session must register with Caroline
Talev at caroline.talev@hhs.gov by close
of business February 6, 2015;
registration for public comment will not
be accepted by telephone. Individuals
are encouraged to provide a written
statement of any public comment(s) for
accurate minute taking purposes. Public
comment will be limited to two minutes
per speaker. Any members of the public
who wish to have printed material
distributed to PACHA members at the
meeting should submit, at a minimum,
1 copy of the material(s) to Caroline
Talev, no later than close of business
close of business February 6, 2015.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
Dated: January 12, 2015.
B. Kaye Hayes,
Executive Director, Presidential Advisory
Council on HIV/AIDS.
[FR Doc. 2015–01428 Filed 1–26–15; 8:45 am]
BILLING CODE 4150–43–P
VerDate Sep<11>2014
18:01 Jan 26, 2015
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee: Notice of Charter
Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Healthcare Infection Control Practices
Advisory Committee, Department of
Health and Human Services, has been
renewed for a 2-year period through
January 19, 2017.
For information, contact Jeffrey
Hageman, M.H.S., Executive Secretary,
Healthcare Infection Control Practices
Advisory Committee, Department of
Health and Human Services, 1600
Clifton Road NE., Mailstop A35,
Atlanta, Georgia 30333, telephone 404/
639–4951 or fax 404/639–2647.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–01381 Filed 1–26–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
Subcommittee on Procedures Review,
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 11 a.m.–5 p.m., EST,
February 18, 2015.
Place: Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number, 1–866–659–0537 and the passcode
is 9933701.
Status: Open to the public. The public is
welcome to submit written comments in
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
4269
advance of the meeting, to the contact person
below. Written comments received in
advance of the meeting will be included in
the official record of the meeting. The public
is also welcome to listen to the meeting by
joining the teleconference at the USA tollfree, dial-in number, 1–866–659–0537 and
the passcode is 9933701.
Background: The ABRWH was established
under the Energy Employees Occupational
Illness Compensation Program Act of 2000 to
advise the President on a variety of policy
and technical functions required to
implement and effectively manage the
compensation program. Key functions of the
ABRWH include providing advice on the
development of probability of causation
guidelines that have been promulgated by the
Department of Health and Human Services
(HHS) as a final rule; advice on methods of
dose reconstruction which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2015.
Purpose: The ABRWH is charged with (a)
providing advice to the Secretary, HHS, on
the development of guidelines under
Executive Order 13179; (b) providing advice
to the Secretary, HHS, on the scientific
validity and quality of dose reconstruction
efforts performed for this program; and (c)
upon request by the Secretary, HHS,
providing advice to the Secretary on whether
there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is a reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee on Procedures
Review was established to aid the ABRWH in
carrying out its duty to advise the Secretary,
HHS, on dose reconstructions. The
Subcommittee on Procedures Review is
responsible for overseeing, tracking, and
participating in the reviews of all procedures
used in the dose reconstruction process by
the NIOSH Division of Compensation
Analysis and Support (DCAS) and its dose
reconstruction contractor (Oak Ridge
Associated Universities—ORAU).
Matters for Discussion: The agenda for the
Subcommittee meeting includes: Discussion
of procedures in the following ORAU and
DCAS technical documents: Procedures for
reconstructing dose associated with potential
skin contamination, ORAU Team Technical
Information Bulletin (OTIB) 0054 (‘‘Fission
and Activation Product Assignment for
Internal Dose-Related Gross Beta and Gross
Gamma Analyses’’), OTIB 0082 (‘‘Dose
Reconstruction Method for Chronic
Lymphocytic Leukemia’’), Program
E:\FR\FM\27JAN1.SGM
27JAN1
Agencies
[Federal Register Volume 80, Number 17 (Tuesday, January 27, 2015)]
[Notices]
[Pages 4268-4269]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01428]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Presidential Advisory Council on HIV/AIDS
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Service (DHHS) is hereby giving notice
that the Presidential Advisory Council on HIV/AIDS (PACHA) will hold a
meeting to discuss essential health benefits and provider networks, the
integration of the Affordable Care Act (ACA) qualified health plan and
the Ryan White Program; an update on the National HIV/AIDS Strategy;
and a discussion on surveillance data. The meeting will be open to the
public.
DATES: The meeting will be held on February 12, 2015, from 9 a.m. to
approximately 5 p.m. (ET) and February 13, 2015, from 9:30 a.m. to
approximately 12:30 p.m. (ET).
ADDRESSES: Renaissance Washington DC, Downtown Hotel, 999 Ninth Street
NW., Washington, DC 20001.
FOR FURTHER INFORMATION CONTACT: Ms. Caroline Talev, Public Health
Analyst, Presidential Advisory Council on HIV/AIDS, U.S. Department of
Health and Human Services, 200 Independence Avenue SW., Room 443H,
Washington, DC 20201; (202) 205-1178. More detailed information about
PACHA can be obtained by accessing the PACHA Web page on the AIDS.Gov
Web site at www.aids.gov/pacha.
[[Page 4269]]
SUPPLEMENTARY INFORMATION: PACHA was established by Executive Order
12963, dated June 14, 1995, as amended by Executive Order 13009, dated
June 14, 1996. The Council was established to provide advice,
information, and recommendations to the Secretary regarding programs
and policies intended to promote effective prevention of HIV disease
and AIDS. The functions of the Council are solely advisory in nature.
The Council consists of not more than 25 members. Council members
are selected from prominent community leaders with particular expertise
in, or knowledge of, matters concerning HIV and AIDS, public health,
global health, philanthropy, marketing or business, as well as other
national leaders held in high esteem from other sectors of society.
Council members are appointed by the Secretary or designee, in
consultation with the White House Office on National AIDS Policy. The
agenda for the upcoming meeting will be posted on the Council's Web
site at www.aids.gov/pacha.
Public attendance at the meeting is limited to space available.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the designated contact person. Due to space constraints, pre-
registration for public attendance is advisable and can be accomplished
by contacting Caroline Talev at caroline.talev@hhs.gov by close of
business February 6, 2015. Members of the public will have the
opportunity to provide comments at the meeting. Any individual who
wishes to participate in the public comment session must register with
Caroline Talev at caroline.talev@hhs.gov by close of business February
6, 2015; registration for public comment will not be accepted by
telephone. Individuals are encouraged to provide a written statement of
any public comment(s) for accurate minute taking purposes. Public
comment will be limited to two minutes per speaker. Any members of the
public who wish to have printed material distributed to PACHA members
at the meeting should submit, at a minimum, 1 copy of the material(s)
to Caroline Talev, no later than close of business close of business
February 6, 2015.
Dated: January 12, 2015.
B. Kaye Hayes,
Executive Director, Presidential Advisory Council on HIV/AIDS.
[FR Doc. 2015-01428 Filed 1-26-15; 8:45 am]
BILLING CODE 4150-43-P